Back to companies

Quince Therapeutics Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Quince Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Quince Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

David A. Lamond

Chairman Executive Board Since: 2015 Age: 51

Dirk Thye, M.D.

Chief Executive Officer; Director; Chief Medical Officer Executive Board Since: 2022 Age: 56

Brigette Roberts, M.D.

Chief Corporate Affairs Officer; Director Executive Board

Brendan Hannah

Chief Compliance Officer; Chief Operating Officer; Chief Business Officer Senior Management Since: 2022 Age: 41

Charles Ryan, Ph.D.

President Senior Management Since: 2023 Age: 61
Gain a 360-degree view of Quince Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Quince Therapeutics Inc and make more informed decisions for your business Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer